Navigation Links
Children's Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts
Date:9/7/2010

BETHLEHEM, Pa., Sept. 7 /PRNewswire/ -- Particle Sciences Inc. (PSI), a leading pharmaceutical Contract Research Organization (CRO), has been engaged by Children's Hospital Boston to help advance early stage molecules and drug innovations into new therapeutic products for patient care. Under the established framework between Children's and PSI, Particle Sciences provides drug product development services aimed at progressing the specific drug or drug product candidate to the point where it becomes attractive to potential licensees. Under the non-exclusive agreement, Children's retains all rights to the drug product, as well as the data and intellectual property created under this arrangement.  

According to Erik Halvorsen, Ph.D., director of the Technology and Innovation Development Office (TIDO) at Children's, "Particle Sciences is one of several CRO's we have chosen to work with. They bring a great deal of experience to the effort in both drug delivery and analytic method development. Importantly, in an early stage exercise such as this we need our partners to remain flexible and to participate as more than simply fee for service providers. Particle Sciences has demonstrated this and we are happy to be working with them."  

The Children's Technology Development Program selects early stage technologies from the world-class staff at Children's and provides enough funding to progress them to meaningful inflection points. This could include activities ranging from establishing pre-clinical data for an IND submission or a solid pre-formulation package leading to process scale up that would enable clinical studies.  Along with funding, the program provides expert advisors with appropriate industrial experience. According to Dr. Mark Mitchnick, CEO at Particle Sciences, "We couldn't be more pleased to be involved with this effort.  Children's Hospital Boston is one of the world's great institutions. The technologies we have seen so far reflect the depth one would expect from such a group and we are thrilled to be able to help commercialize them."Contact:Maureen CochranParticle Sciencesmcochran@particlesciences.comParticle Sciences is an integrated provider of drug development services.  Particle Sciences is expert in formulating difficult to solubilze API's using traditional and nano-based approaches.  We bring that skill set to bear on a variety of dosage forms including topical, mucosal, oral and parenteral drug products.  Particle Sciences is also a leader in combination drug/device product development.  Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic.  The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania.  Visit www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861- 4701 for information.


'/>"/>
SOURCE Particle Sciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology
2. St. Jude Childrens Research Hospital Doctors and Scientists Team up to Fight Childhood Cancer
3. Morehead Memorial Hospital Goes Live with Thomson Reuters Clinical Xpert CareFocus
4. Fortis Hospitals India Does Asias First Custom Fit Knee Replacement Surgery
5. Hospital Room of the Future Debuts in New Jersey
6. Health Connect Partners Welcomes Cardinal Health as Title Sponsor of the 2010 Hospital O.R. & Surgery Center Conference
7. Southwest Hospitals MRI Centers Commitment to State-of-the-Art Technology at the Heart of Nearly 20-Year Relationship with MedInformatix RIS
8. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
9. Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community
10. RF Technologies(R) Installs Updated Version of its Safe Place(R) Solution for Infant Security at Sutter Tracy Community Hospital
11. Sharp HealthCare Selects Allscripts Community Record to Deliver End-to-End Health Information Connectivity for San Diego Physicians and Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... Phytomer USA ... As a Phytomer Account Manager, Smith’s role is to provide excellent customer ... that make up The Phytomer Group. Smith comes to Phytomer with a wealth of ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of New Jersey ... “A” and its outlook as “stable.” At the same time, the ratings agency cautioned ... recent years, dip below “capital adequacy” thresholds required for its strong rating. , “Horizon ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management ... officers for 2017-2018. The annual board election process has been in place since the ... , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... liability could substantially improve drug safety and minimize the cost of development. In ... ion channel inhibition using cell lines and for cardiac toxicity using induced pluripotent ...
Breaking Medicine News(10 mins):